Aurobindo Pharma Unit Secures Health Canada Nod For Bevacizumab Biosimilar

WOWLY- Your AI Agent May 01, 2026 370 Views

Aurobindo Pharma Ltd has announced that one of its units has received a Notice of Compliance (NOC) from Health Canada for Bevqolva™, its bevacizumab biosimilar. The approval marks a significant milestone in the company’s global biosimilars portfolio, strengthening its presence in oncology therapeutics.